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Introduction
Clinical assessment of disease severity is an important part of medical practice to predict mortality and morbidity in Intensive Care Unit (ICU)
1 . An acceptable goal in ICU is saving the lives of critically ill patients, since not all patients admitted to an ICU have a normal life after leaving and some will not survive because of disease severity 2 .
Specialties of ICUs should predict patient outcomes to focus more on efficient use of ICU beds for critically ill patients 2 . Disease severity scoring systems can be used as a guidance for clinicians in the objective assessment of disease outcomes and estimation of the chance of recovery 2 . Acute Physiology And Chronic Health Evaluation (APACHE), introduced in 1981, considers various parameters, including vital signs, physiological variables, neurological score, urine output, age, and comorbid conditions 3 . The latest version of APACHE-IV is calculated based on 129 variables derived within the first 24 h of ICU admission 1 , which were assessed from over 110,588 patients admitted to more than 104 ICUs across the USA 4,5 . Some studies have suggested the superior advantage of APACHE-IV compared to other risk scoring systems 6,7 .
Evaluation of clinical outcomes and effectiveness of care in ICU patients is influenced by predictive scoring models that compute measures of disease severity and the associated probability of death. APACHE is a logistic regression model involving both physiological and laboratory parameters. It is a commonly used ICU stratification instrument, which is known as an accurate predictor of mortality. Yet, model accuracy decreases over time and requires updating occasionally. A study conducted in 2012 indicated that APACHE-III performance was inadequate even with a predicted mortality of only 2% higher than the observed mortality rate (16% vs. 14%) 8 . A similar study conducted on APACHE-IV showed that the ICU's outcome prediction by the model is different to observed values in clinical setting between the predicted and the observed mortality rate 9 .
To our knowledge, no study has been conducted to evaluate the accuracy of APACHE-IV for predicting mortality and length of stay in emergency ICUs in Iran. This study aimed to evaluate the hypothesis that the mortality and length of stay in emergency ICUs predicted by APACHE-IV is different than that observed in reality.
Methods
This was a retrospective cohort study conducted on the medical records of 839 consecutive patients admitted in the emergency ICUs in Nemazi Hospital, Shiraz, Iran, between July 2012 and July 2015. The patients of this study were selected from all patients referred to the ICUs of the Center during the study period using convenient sampling method. The total number of patients admitted during this period was 839. The inclusion criterion was minimum 24 hour admission in the ICU and there was no exclusion criterion for this study. The Namazi Hospital is a tertiary referral hospital affiliated to Shiraz University of Medical Sciences, Shiraz, Iran. All the experimental procedures and study protocol of the study were approved by the local ethics committee of Shiraz University of Medical Sciences (protocol no. 94-7636), which were in complete accordance with the ethical standards and regulations of human studies of the Declaration of Helsinki (2014).
The medical records of 839 consecutive patients admitted to the emergency ICUs of Nemazi Hospital were analyzed. The variables used to calculate APACHE-IV score included age, sex, dates of admission, discharge or death, systolic and diastolic blood pressure, body temperature, heart rate, respiratory rate, glucose, blood urea nitrogen, serum sodium, creatinine, blood hematocrit, white blood cells, serum albumin and bilirubin, urine output during the first 24 h of ICU admission, pH, fraction of inspired oxygen, partial pressure of carbon dioxide, partial pressure of oxygen, and bicarbonate
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Death or discharge and length of stay in ICU were followed up by referring to patients' medical records. Additionally, APACHE-IV score, Glasgow coma score (GCS), and acute physiology score (APS) were calculated according to www. cerner.com (the authors registered as a user in order to calculate all the parameters).
Statistical analysis
Qualitative variables were expressed as number and percentage, and quantitative variables as mean ± standard deviation. Student's t-test, Mann-Whitney U, Wilcoxon rank test, and Chi-square tests were used where appropriate to compare survivors and non-survivors regarding demographic and clinical variables. In addition, Spearman's correlation coefficient was used to examine the relationship between APACHE-IV score and length of stay in ICU. Finally, accuracy of APACHE-IV for mortality was assessed using area under the Receiver Operator Characteristic (ROC) curve with an attribution of 'good' > 0.80. The data are expressed as mean ± SD for all variables. All statistical analyses were carried out using Stata (version 13, Windows). As the distribution of the quantitative variables was not normal, Mann Whitney U test was used for comparisons of the difference between the survivor and non-survivor groups. For the sex variable the Chi-square test was used. p ≤ 0.05 was considered to be statistically significant.
Results
This study was conducted on 839 patients among whom, 157 died and 682 were discharged (non-survivors and survivors, respectively). The length of stay in ICU was 10.98±14.60, 10.22±14.21, and 14.30±15.80 days in all patients, survivors, and non-survivors, respectively. Demographic information and the clinical features of the patients are summarized in Table 1 .
The results showed no significant difference between the two groups regarding sex (p=0.243). However, the two groups were significantly different with respect to the means of age (p≤0.001), ICU length of stay (p≤0.001), GCS (p≤0.001), APACHE-IV score (p≤0.001), and APS (p≤0.001) ( Table 1) .
Evaluation of APACHE-IV score
Outcome variables have been summarized in Table 2 . Accordingly, mean ± SD of observed length of stay in ICU was 10.98±14.60 days. However, predicted ICU length of stay by the APACHE-IV model was 5.43±2.50 days (p<0.001). This indicated that APACHE-IV underestimated ICU length of stay in our emergency ICU. Additionally, the overall observed mortality was 17.8%, while the predicted mortality by APACHE-IV was 21%. Thus, mortality was overestimated by APACHE-IV model with an absolute difference of 3.2% (p=0.036).
ROC curve for APACHE-IV score and observed mortality has been depicted in Figure 1 . Accordingly, area under the curve of the APACHE-IV score was 0.81, 95% CI (0.77, 0.84). These values were statistically significant and could be an appropriate predictor for observed mortality. Nevertheless, there was a significant weak correlation between APACHE-IV score and observed ICU length of stay (r=0.175, p<0.0001). 
Discussion
A retrospective cohort study was conducted among 839 patients referred to ICU at Namazi Hospital in Shiraz, Iran. The study results showed that APACHE-IV underestimated the length of stay in our emergency ICU. In addition, the overall observed mortality was 17.8%, while the predicted mortality by APACHE-IV was 21%. Thus, there was an overestimation of predicted mortality by APACHE-IV, with an absolute difference of 3.2% (p=0.036).
Several factors may contribute to poor performance of APACHE-IV in emergency ICU. APACHE-IV is a good benchmark to determine disease severity; however, the present study results indicated that it did not function well to predict the risk of mortality and length of stay in emergency ICU. Other studies also reported this score not to be predictive of mortality 10, 11 . The poor estimate may be attributed to various reasons. Firstly, the estimations were achieved based on American rather than our own patients' data. Generally, predictive scoring systems function appropriately in populations where scores are derived from the same population data. Therefore, many experts recommend external validation at national, regional, or institutional levels. For example, APS3 has several customized versions for seven geographic regions 12, 13 . Secondly, in America, where APACHE was calibrated, patients go from ICU to 'step down', a halfway ward, before moving to general wards. In Iran, patients directly go to general wards, and consequently, they have to stay in ICUs for a longer time period than American patients.
Thirdly, even if scores are achieved by patients' data, they must be calibrated over time. This is because case-mix varies, quality of care improves, and types of disease changes over time. In general, accurate calibration is a key characteristic that should be ensured for all risk scoring systems. Calibration may weaken over time, especially due to the effects of altered patient interventions and case-mix. This often results in overestimation of death or mortality 14 .
The findings of the present study revealed that APACHE-IV score based on our data would be an appropriate predictor for the observed mortality, while this relationship was not confirmed by the APACHE-IV score according to the American database 9 . Moreover, our findings showed a similar relationship between APACHE-IV score and ICU length of stay with the study conducted on the United States database 9 . Overall, a large patient's database should exist in order for APACHE-IV to correctly predict outcomes (i.e. mortality and ICU length of stay).
Strengths and limitations of the study
The strength of this study should be noted. This study is the first study in Iran that demonstrated that predictions of mortality and ICU length of stay should be based on data obtained from Iranian and not American patients. However, this study had some limitations, the first of which being the intrinsic shortcomings of its retrospective design (inability to confirm causation, and dependence on medical records). Another study limitation was its small sample size; however, to date, our cohort of 839 patients is the largest reported study of patients admitted to emergency ICUs in Iran.
In conclusion, the findings of this study suggested that the American based APACHE-IV score is a poor predictor of length of stay and mortality in emergency ICU in Iran. Therefore, specific models based on big sample sizes of our patients from Iran are required to improve the accuracy of predictions of mortality and ICU length of stay for our country.
Data availability
Dataset 1: Data for the study on efficacy of APACHE-IV for predicting mortality and length of stay in an intensive care unit in Iran. doi, 10.5256/f1000research.12290.d177987 The manuscript entitled "A study on the efficacy of APACHE-IV for predicting mortality and length of stay " was reviewed. This is a well conducted study with appropriate in an intensive care unit in Iran methodology. The data provided are of good volume and with enough details. The sample size is of particularly important resulting in the more robust evidence. The authors could appropriately discussed the results and compared their findings with the similar conducted studies. Conducting further studies in the country with big sample size in the ICU patients can shed further lights to adopt appropriate policies for improving the healthcare conditions and reducing the mortality rate of ICU patients. Coherence between the paper's summary and its content c
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